These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 15374579

  • 1. Antisaccade performance in biological relatives of schizophrenia patients: a meta-analysis.
    Levy DL, O'Driscoll G, Matthysse S, Cook SR, Holzman PS, Mendell NR.
    Schizophr Res; 2004 Nov 01; 71(1):113-25. PubMed ID: 15374579
    [Abstract] [Full Text] [Related]

  • 2. Antisaccade performance is abnormal in schizophrenia patients but not in their biological relatives.
    Brownstein J, Krastoshevsky O, McCollum C, Kundamal S, Matthysse S, Holzman PS, Mendell NR, Levy DL.
    Schizophr Res; 2003 Sep 01; 63(1-2):13-25. PubMed ID: 12892854
    [Abstract] [Full Text] [Related]

  • 3. Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients.
    Calkins ME, Curtis CE, Iacono WG, Grove WM.
    Schizophr Res; 2004 Nov 01; 71(1):167-78. PubMed ID: 15374584
    [Abstract] [Full Text] [Related]

  • 4. Does performance on the standard antisaccade task meet the co-familiality criterion for an endophenotype?
    Levy DL, Bowman EA, Abel L, Krastoshevsky O, Krause V, Mendell NR.
    Brain Cogn; 2008 Dec 01; 68(3):462-75. PubMed ID: 18842329
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia.
    Mazhari S, Price G, Dragović M, Waters FA, Clissa P, Jablensky A.
    Brain Cogn; 2011 Nov 01; 77(2):223-30. PubMed ID: 21924537
    [Abstract] [Full Text] [Related]

  • 10. Antisaccade error rates in first-episode psychosis, ultra-high risk for psychosis and unaffected relatives of schizophrenia: A systematic review and meta-analysis.
    Ekin M, Akdal G, Bora E.
    Schizophr Res; 2024 Apr 01; 266():41-49. PubMed ID: 38367611
    [Abstract] [Full Text] [Related]

  • 11. The effect of fixation condition manipulations on antisaccade performance in schizophrenia: studies of diagnostic specificity.
    McDowell JE, Clementz BA.
    Exp Brain Res; 1997 Jun 01; 115(2):333-44. PubMed ID: 9224861
    [Abstract] [Full Text] [Related]

  • 12. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study.
    Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW.
    Psychophysiology; 2010 Sep 01; 47(5):846-56. PubMed ID: 20374545
    [Abstract] [Full Text] [Related]

  • 13. A concordance study of three electrophysiological measures in schizophrenia.
    Louchart-de la Chapelle S, Nkam I, Houy E, Belmont A, Ménard JF, Roussignol AC, Siwek O, Mezerai M, Guillermou M, Fouldrin G, Levillain D, Dollfus S, Campion D, Thibaut F.
    Am J Psychiatry; 2005 Mar 01; 162(3):466-74. PubMed ID: 15741463
    [Abstract] [Full Text] [Related]

  • 14. Eye tracking in schizophrenia: does the antisaccade task measure anything that the smooth pursuit task does not?
    Zanelli J, Simon H, Rabe-Hesketh S, Walshe M, McDonald C, Murray RM, Maccabe JH.
    Psychiatry Res; 2005 Sep 15; 136(2-3):181-8. PubMed ID: 16111769
    [Abstract] [Full Text] [Related]

  • 15. Successful multi-site measurement of antisaccade performance deficits in schizophrenia.
    Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW.
    Schizophr Res; 2007 Jan 15; 89(1-3):320-9. PubMed ID: 17023145
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Eye tracking disorders in schizophrenic patients and their parents].
    Boudet C, Denise P, Bocca ML, Chabot B, Abadie P, Brazo P, Benali K, Dollfus S.
    Encephale; 2001 Jan 15; 27(6):551-8. PubMed ID: 11865562
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Poor antisaccade performance in schizophrenia: an inhibition deficit?
    Reuter B, Rakusan L, Kathmanna N.
    Psychiatry Res; 2005 May 15; 135(1):1-10. PubMed ID: 15893384
    [Abstract] [Full Text] [Related]

  • 20. Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study.
    Ettinger U, Picchioni M, Hall MH, Schulze K, Toulopoulou T, Landau S, Crawford TJ, Murray RM.
    Am J Psychiatry; 2006 Mar 15; 163(3):543-5. PubMed ID: 16513882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.